Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 12.74 CNY -7.28% Market Closed
Market Cap: 5.3B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Novogene Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Long-Term Debt
ÂĄ16.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Long-Term Debt
ÂĄ4B
CAGR 3-Years
26%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Long-Term Debt
ÂĄ4.8B
CAGR 3-Years
2%
CAGR 5-Years
41%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Long-Term Debt
ÂĄ3.5B
CAGR 3-Years
2%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Long-Term Debt
ÂĄ791.6m
CAGR 3-Years
28%
CAGR 5-Years
35%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Long-Term Debt
ÂĄ1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Novogene Co Ltd
Glance View

Market Cap
5.3B CNY
Industry
Life Sciences Tools & Services

Novogene Co., Ltd. engages in the provision of genomic services and solutions. The company is headquartered in Beijing, Beijing and currently employs 2,284 full-time employees. The company went IPO on 2021-04-13. The firm mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. At the same time, based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The firm's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The firm conducts its businesses in domestic and overseas markets.

Intrinsic Value
22.68 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

What is Novogene Co Ltd's Long-Term Debt?
Long-Term Debt
16.8m CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Long-Term Debt amounts to 16.8m CNY.

What is Novogene Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 1Y
-40%

Over the last year, the Long-Term Debt growth was -40%.

Back to Top